Literature DB >> 28124645

Paradigm shifts in the medical and surgical management of rhinologic and allergic disease.

Jivianne T Lee.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 28124645      PMCID： PMC5108837          DOI： 10.2500/ajra.2016.30.4398

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN： 1945-8932            Impact factor:   2.467


× No keyword cloud information.
  23 in total

Review 1.  New routes of allergen immunotherapy.

Authors:  Mitat Aricigil; Nuray Bayar Muluk; Engin Umut Sakarya; Emine Güven Sakalar; Mehmet Senturk; William R Reisacher; Cemal Cingi
Journal:  Am J Rhinol Allergy       Date:  2016-11-01       Impact factor: 2.467

2.  Local allergic rhinitis to pollens is underdiagnosed in young patients.

Authors:  Anna Krajewska-Wojtys; Jerzy Jarzab; Radoslaw Gawlik; Andrzej Bozek
Journal:  Am J Rhinol Allergy       Date:  2016-11-01       Impact factor: 2.467

Review 3.  Open versus endoscopic septoplasty techniques: A systematic review and meta-analysis.

Authors:  Chris J Hong; Eric Monteiro; Jetan Badhiwala; John Lee; John R de Almeida; Allan Vescan; Ian J Witterick
Journal:  Am J Rhinol Allergy       Date:  2016-11-01       Impact factor: 2.467

4.  Novel use of an ultrasonic bone aspirator for extended endoscopic frontal sinusotomy: A feasibility study.

Authors:  Conner J Massey; Sean Bury; Jay Diamond; Ameet Singh
Journal:  Am J Rhinol Allergy       Date:  2016-11-01       Impact factor: 2.467

5.  Olfactory cleft computed tomography analysis and olfaction in chronic rhinosinusitis.

Authors:  Preeti Kohli; Rodney J Schlosser; Kristina Storck; Zachary M Soler
Journal:  Am J Rhinol Allergy       Date:  2016-11-01       Impact factor: 2.467

6.  Failure of itraconazole to prevent T-helper type 2 cell immune deviation: Implications for chronic rhinosinusitis.

Authors:  Joshua L Kennedy; John W Steinke; Lixia Liu; Julie Negri; Larry Borish; Spencer C Payne
Journal:  Am J Rhinol Allergy       Date:  2016-11-01       Impact factor: 2.467

7.  Rapamycin inhibits transforming growth factor beta 1 induced myofibroblast differentiation via the phosphorylated-phosphatidylinositol 3-kinase mammalian target of rapamycin signal pathways in nasal polyp-derived fibroblasts.

Authors:  Dong-Yn Ko; Jae-Min Shin; Ji-Young Um; Byungjin Kang; Il-Ho Park; Heung-Man Lee
Journal:  Am J Rhinol Allergy       Date:  2016-11-01       Impact factor: 2.467

8.  Practice patterns in pediatric chronic rhinosinusitis: A survey of the American Rhinologic Society.

Authors:  Daniel M Beswick; Hassan Ramadan; Fuad M Baroody; Peter H Hwang
Journal:  Am J Rhinol Allergy       Date:  2016-11-01       Impact factor: 2.467

9.  Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis.

Authors:  Fenna A Ebbens; Glenis K Scadding; Lydia Badia; Peter W Hellings; Mark Jorissen; Joaquim Mullol; Alda Cardesin; Claus Bachert; Thibaut P J van Zele; Marcel G W Dijkgraaf; Valerie Lund; Wytske J Fokkens
Journal:  J Allergy Clin Immunol       Date:  2006-11       Impact factor: 10.793

10.  Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study.

Authors:  Kai-Li Liang; Mao-Chang Su; Jiun-Yi Shiao; Hung-Cheng Tseng; Chung-Han Hsin; Jen-Fu Lin; Rong-San Jiang
Journal:  Am J Rhinol       Date:  2008 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.